Group News - BYHEALTH

Group News

 Home > About Us > Group News

We always have something new



Leading with strategic initiative— 2025 Letter to Shareholders from the Chairman of BYHEALTH

Leading with strategic initiative in 2025 must also focus on eliminating unnecessary work and cutting budgets that do not contribute to product value, user value, or operational value. As a company still in its growth phase, we must avoid turning "operations" into "management," which can lead to premature stagnation and the risks of organizational complacency.

BYHEALTH and Chinese Scientists Collaborate on a Groundbreaking Metabolic Health Evaluation System

BYHEALTH, in collaboration with the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, and the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences achieved a pioneering breakthrough in their research on a “Homeostasis-Based Health Evaluation System.”

Nature spotlights BYHEALTH R&D innovations on scientific nutrition，including PCC1 and patented probiotics

On June 15, Nature the authoritative scientific journal published a supplement on nutrition researches in China for the first time, and released an interview article EXPLORING NEW FRONTIERS IN HEALTH MANAGEMENT THROUGH NUTRITION RESEARCH, highlighted several cutting-edge research results of BYHEALTH R&D innovations on scientific nutrition, including PCC1 and patented probiotics.

The World’s First Large-scale Study of Association of NAD+ Contents with Aging

The research is jointly directed by Shanghai General Hospital Affiliated to School of Medicine, Shanghai Jiao Tong University (SJTU), Jinan University and BYHEALTH Nutrition and Health Research Institute, in collaboration with many other famous national and international institutions of higher education and scientific research institutes.

Two National Invention Patents Conferred on BYHEALTH’s Self-developed Indigenous Strain

China's local probiotics family welcomes another new member. With 7 years of strenuous effort, Lactobacillus Paracasei LPB27, a fine intestinal strain originated from healthy Chinese infants, sees the light of day.



News

The World’s First Large-scale Study of Association of NAD+ Contents with Aging

The World’s First Large-scale Study of Association of NAD+ Contents with Aging

The research is jointly directed by Shanghai General Hospital Affiliated to School of Medicine, Shanghai Jiao Tong University (SJTU), Jinan University and BYHEALTH Nutrition and Health Research Institute, in collaboration with many other famous national and international institutions of higher education and scientific research institutes.

Opens the New Cycle of Vitamins and Dietary Supplements——2023 Letter to the shareholders from the Chairman of Byhealth

Opens the New Cycle of Vitamins and Dietary Supplements——2023 Letter to the shareholders from the Chairman of Byhealth

2023 is the first year of the post-pandemic era as well as the first year of the new VDS cycle.

Two National Invention Patents Conferred on BYHEALTH’s Self-developed Indigenous Strain

Two National Invention Patents Conferred on BYHEALTH’s Self-developed Indigenous Strain

China's local probiotics family welcomes another new member. With 7 years of strenuous effort, Lactobacillus Paracasei LPB27, a fine intestinal strain originated from healthy Chinese infants, sees the light of day.

BYHEALTH becomes the Sports Foods and Nutrition Supplier of TEAM CHINA, facilitating the Team in competitions

BYHEALTH becomes the Sports Foods and Nutrition Supplier of TEAM CHINA, facilitating the Team in competitions

On December 28, 2021, the Sports Equipment and Facilities Center of the General Administration of Sport of China announced on its award ceremony that BYHEALTH has become the Sports Foods and Nutrition Supplier of TEAM CHINA, providing sports food, nutritional products and professional nutritional plans for over 70 national teams.

Build an Enterprise with Strong Technology in Another 8 Years

Build an Enterprise with Strong Technology in Another 8 Years

In 2022, we need "quantity" with more quality, health and sustainability. Without 1 (the health), the 0 after it, no matter how many there are, is meaningless. If Byhealth cannot create ongoing incremental value for consumers' health and its stakeholders in the ecosystem, it will cease to exist.

KEYLID Appointed as Official Supplier of Bone & Joint Health Supplements for Hangzhou Asian Games

KEYLID Appointed as Official Supplier of Bone & Joint Health Supplements for Hangzhou Asian Games

On January 1, 2022, KEYLID of BYHEALTH was appointed as the Official Supplier of Bone & Joint Health Supplements for the 19th Asian Games Hangzhou 2022. With its “science-based nutrition” strategy, KEYLID wishes to provide professional care for bone & joint and support the development of Chinese sports.

<
1
2
3
4
>